At SoCal Biosciences, we pride ourselves on being a trusted partner for RNA-related projects. Led by Dr. Patty Limphong, who brings over a decade of experience in RNA drug development and therapeutics, our team specializes in bioanalytical assays for mRNA and oligonucleotides.
Our expertise has supported numerous clients in developing and quantifying RNA and protein assays, contributing to multiple drug development projects approved by IND and CTA for clinical trials. Notably, our data played a pivotal role in the regulatory submission of KOSTAIVE®, the first commercialized sa-mRNA COVID-19 vaccine.
We maintain a meticulous approach to RNA analysis, ensuring an RNase-free environment with dedicated workspaces and specialized equipment. Our commitment to precision and reliability makes SoCal Biosciences the preferred choice for advancing RNA-focused research and therapeutics.
Join leading researchers and drug developers who trust our bioanalytical CRO expertise. Receive exclusive content, industry insights, and innovative methodologies straight to your inbox.